CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson's disease: a study in LRRK2 mutation carriers.

Transl Neurodegener · 2020 · PMC7201744 · PMID 32375873

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Examination of CSF levels of pS129-α-syn revealed a trend of an increase in sPD group (median and IQR = 139 (114.25–163) pg/ml, n = 60) compared to Ctrl (median and IQR = 116 (103–145) pg/ml, n = 43), however the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.